Source: International Congress 2016 – Surgical strategy for complex diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Cagatay Tezel (Istanbul, Turkey), Cagatay Tezel, Talha Dogruyol, Levent Alpay, Mustafa Akyil, Serdar Evman, Serda Metin, Volkan Baysungur, Irfan Yalcinkaya. Does the type of N1 state different survival. Eur Respir J 2016; 48: Suppl. 60, 2501

Member's Comments

No comment yet.

Related content which might interest you: Futile thoracotomy in lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Reducing the rate of emergency presentation in lung cancer Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Diaphragm invasion worsen the prognosis as indicated in the 8th TNM Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Segmentectomy for second lung cancer after lobectomy Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Operative morbidity and mortality of different types of pneumonectomyfor lung cancer Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery Year: 2014 Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit? Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Review of stage 1/2 non-resected NSCLC against international guidance Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Reduced perioperative mortality after centralization of lung cancer surgery Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Pulmonary nodules in the setting of an extrapulmonary tumor - 5 year review Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery Year: 2014 Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Survival after lung metastasis resection. Review of 17 years in our centre Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013